NZ744885A - Method for preparing pyrrolo[3,2-d]pyrimidine compound, and intermediates thereof - Google Patents

Method for preparing pyrrolo[3,2-d]pyrimidine compound, and intermediates thereof

Info

Publication number
NZ744885A
NZ744885A NZ744885A NZ74488517A NZ744885A NZ 744885 A NZ744885 A NZ 744885A NZ 744885 A NZ744885 A NZ 744885A NZ 74488517 A NZ74488517 A NZ 74488517A NZ 744885 A NZ744885 A NZ 744885A
Authority
NZ
New Zealand
Prior art keywords
compound
formula
acid
group
sodium
Prior art date
Application number
NZ744885A
Other languages
English (en)
Inventor
Zhaozhong Ding
Ling Yang
Fei Sun
Yinghu Hu
Yilong Zhou
Rui Zhao
Original Assignee
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chia Tai Tianqing Pharmaceutical Group Co Ltd filed Critical Chia Tai Tianqing Pharmaceutical Group Co Ltd
Publication of NZ744885A publication Critical patent/NZ744885A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
NZ744885A 2016-02-05 2017-02-04 Method for preparing pyrrolo[3,2-d]pyrimidine compound, and intermediates thereof NZ744885A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201610082028.3A CN107043378A (zh) 2016-02-05 2016-02-05 一种吡咯并[3,2-d]嘧啶类化合物的制备方法及其中间体
PCT/CN2017/072893 WO2017133686A1 (zh) 2016-02-05 2017-02-04 一种吡咯并[3,2-d]嘧啶类化合物的制备方法及其中间体

Publications (1)

Publication Number Publication Date
NZ744885A true NZ744885A (en) 2022-07-01

Family

ID=59500148

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ744885A NZ744885A (en) 2016-02-05 2017-02-04 Method for preparing pyrrolo[3,2-d]pyrimidine compound, and intermediates thereof

Country Status (28)

Country Link
US (2) US10654856B2 (OSRAM)
EP (1) EP3412673B1 (OSRAM)
JP (1) JP6877449B2 (OSRAM)
KR (1) KR102371500B1 (OSRAM)
CN (2) CN107043378A (OSRAM)
AR (1) AR107549A1 (OSRAM)
AU (1) AU2017214134B2 (OSRAM)
BR (1) BR112018015879B1 (OSRAM)
CA (1) CA3013520C (OSRAM)
CL (1) CL2018002094A1 (OSRAM)
DK (1) DK3412673T3 (OSRAM)
EA (1) EA034581B1 (OSRAM)
ES (1) ES2852323T3 (OSRAM)
HR (1) HRP20210103T1 (OSRAM)
HU (1) HUE053455T2 (OSRAM)
IL (1) IL260999B (OSRAM)
LT (1) LT3412673T (OSRAM)
MX (1) MX374298B (OSRAM)
MY (1) MY190551A (OSRAM)
NZ (1) NZ744885A (OSRAM)
PH (1) PH12018501642B1 (OSRAM)
PL (1) PL3412673T3 (OSRAM)
PT (1) PT3412673T (OSRAM)
SG (1) SG11201806685VA (OSRAM)
SI (1) SI3412673T1 (OSRAM)
TW (1) TW201728590A (OSRAM)
UA (1) UA124100C2 (OSRAM)
WO (1) WO2017133686A1 (OSRAM)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107043380A (zh) 2016-02-05 2017-08-15 正大天晴药业集团股份有限公司 一种tlr7激动剂的马来酸盐、其晶型c、晶型d、晶型e、制备方法和用途
KR102808827B1 (ko) 2016-02-05 2025-05-19 데날리 테라퓨틱스 인크. 수용체-상호작용 단백질 키나제 1의 억제제
WO2020162705A1 (ko) 2019-02-08 2020-08-13 성균관대학교산학협력단 톨-유사 수용체 7 또는 8 작용자와 콜레스테롤의 결합체 및 그 용도
WO2021177679A1 (ko) 2020-03-02 2021-09-10 성균관대학교산학협력단 병원균 외벽 성분 기반 생병원체 모방 나노 입자 및 그 제조 방법
EP4194010A4 (en) 2020-08-04 2025-03-26 Progeneer Inc. Conjugate of a functional drug and a toll-like receptor 7 or 8 agonist with a temporarily inactivated drug site, and use thereof
JP7690221B2 (ja) 2020-08-04 2025-06-10 プロジェニア インコーポレイテッド 動力学的に作用するアジュバントアンサンブル
CN116322751A (zh) 2020-08-04 2023-06-23 蛋白科技先锋 包含能够动力学控制的佐剂的mRNA疫苗
JP2025503642A (ja) 2022-01-12 2025-02-04 デナリ セラピューティクス インコーポレイテッド (s)-5-ベンジル-n-(5-メチル-4-オキソ-2,3,4,5-テトラヒドロピリド[3,2-b][1,4]オキサゼピン-3-イル)-4h-1,2,4-トリアゾール-3-カルボキサミドの結晶性形態

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009082247A1 (en) * 2007-12-21 2009-07-02 Industrial Research Limited Process for preparing immucillins having a methylene link
PE20120106A1 (es) 2008-12-09 2012-02-20 Gilead Sciences Inc Moduladores de receptores tipo toll
DK2906563T3 (en) * 2012-10-10 2018-06-06 Janssen Sciences Ireland Uc PYRROLO [3,2-D] PYRIMIDINE DERIVATIVES FOR TREATING VIRUS INFECTIONS AND OTHER DISEASES
PT2922549T (pt) * 2012-11-20 2017-09-01 Glaxosmithkline Llc Novos compostos
WO2014081644A1 (en) * 2012-11-20 2014-05-30 Glaxosmithkline Llc Novel compounds
CR20160512A (es) * 2014-05-01 2016-12-21 Novartis Ag Compuestos y composiciones como agonistas del receptor tipo toll 7
CN105367576A (zh) 2014-08-15 2016-03-02 正大天晴药业集团股份有限公司 作为tlr7激动剂的吡咯并嘧啶化合物
BR112017002811B1 (pt) * 2014-08-15 2022-09-06 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Compostos de pirrolopirimidina usados como agonista de tlr7 e seu uso, composição farmacêutica e kit
JP6524355B2 (ja) * 2015-11-05 2019-06-05 チア タイ ティエンチン ファーマシューティカル グループ カンパニー リミテッドChia Tai Tianqing Pharmaceutical Group Co., Ltd. Tlr7アゴニストとしての7−(チアゾール−5−イル)ピロロピリミジン化合物
CN107043380A (zh) * 2016-02-05 2017-08-15 正大天晴药业集团股份有限公司 一种tlr7激动剂的马来酸盐、其晶型c、晶型d、晶型e、制备方法和用途
CN107043379A (zh) 2016-02-05 2017-08-15 正大天晴药业集团股份有限公司 一种tlr7激动剂的晶型a、其制备方法和医药用途
CN107043377A (zh) * 2016-02-05 2017-08-15 正大天晴药业集团股份有限公司 一种tlr7激动剂的三氟乙酸盐、晶型b及其制备方法、药物组合物和用途

Also Published As

Publication number Publication date
EP3412673B1 (en) 2020-11-25
SI3412673T1 (sl) 2021-04-30
CA3013520C (en) 2022-07-19
HUE053455T2 (hu) 2021-06-28
KR102371500B1 (ko) 2022-03-07
AU2017214134B2 (en) 2020-08-27
AR107549A1 (es) 2018-05-09
EA034581B1 (ru) 2020-02-21
EA201891769A1 (ru) 2019-04-30
JP2019505531A (ja) 2019-02-28
CL2018002094A1 (es) 2018-12-07
WO2017133686A1 (zh) 2017-08-10
BR112018015879A2 (pt) 2018-12-26
MY190551A (en) 2022-04-27
EP3412673A1 (en) 2018-12-12
KR20180104724A (ko) 2018-09-21
PL3412673T3 (pl) 2021-07-26
PT3412673T (pt) 2021-02-15
PH12018501642A1 (en) 2019-06-03
MX2018009502A (es) 2018-12-11
JP6877449B2 (ja) 2021-05-26
IL260999B (en) 2021-02-28
CN108602832B (zh) 2020-10-09
CN107043378A (zh) 2017-08-15
US20190040072A1 (en) 2019-02-07
US10654856B2 (en) 2020-05-19
CN108602832A (zh) 2018-09-28
ES2852323T3 (es) 2021-09-13
PH12018501642B1 (en) 2019-06-03
LT3412673T (lt) 2021-03-10
DK3412673T3 (da) 2021-01-18
HK1259183A1 (zh) 2019-11-29
UA124100C2 (uk) 2021-07-21
HRP20210103T1 (hr) 2021-03-05
BR112018015879B1 (pt) 2024-02-15
SG11201806685VA (en) 2018-09-27
AU2017214134A1 (en) 2018-08-23
US20200239484A1 (en) 2020-07-30
TW201728590A (zh) 2017-08-16
CA3013520A1 (en) 2017-08-10
MX374298B (es) 2025-03-06
EP3412673A4 (en) 2019-07-03

Similar Documents

Publication Publication Date Title
NZ744885A (en) Method for preparing pyrrolo[3,2-d]pyrimidine compound, and intermediates thereof
CA3013518C (en) Tlr7 agonist crystalline form a, preparation method and use thereof
AU2017214135B2 (en) TLR7 agonist trifluoroacetate salt and crystalline form B thereof, preparation methods and uses
CZ293482B6 (cs) DihydropyrimidinyŹ způsob jejich výrobyŹ léčiva tyto látky obsahující a jejich použití
NO141163B (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyrimidiner
NZ554119A (en) Process for the preparation of 4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-N-methylpyridine-2-carboxamide
AU2017215800B2 (en) TLR7 agonist maleate salt, crystalline forms C, D and E thereof, preparation methods and uses of maleate salt and crystalline forms
US20060287541A1 (en) Method for producing nitrile compound, carboxylic acid compound or carboxylate compound
CZ20032654A3 (cs) Způsob výroby 4,6-diaminopyrimido(5,4-d)pyrimidinů
EP0622367A1 (en) Novel quinolone carboxylic acid derivatives and process for preparing the same
JPS634544B2 (OSRAM)
US2864825A (en) Pyrrolidines
SK286442B6 (sk) Spôsob prípravy N-metyl-N-[(1S)-1-fenyl-2-((3S)-3- hydroxypyrolidin-1-yl)etyl]-2,2-difenylacetamidu
HK1259183B (zh) 一种吡咯并[3,2-d]嘧啶类化合物的制备方法及其中间体
US4568744A (en) Benzylpyrimidine synthesis and intermediates
NO882085L (no) Cyklobutenmellomprodukt.
KR800001685B1 (ko) 피리도[2,3-d]피리미딘 유도체의 제조방법
WO2016133940A1 (en) Anticancer agents and process of making thereof
WO2022202814A1 (ja) ピリミジン化合物の製造方法
US20040254181A1 (en) Process for the preparation of 9-deazaguanine derivatives
HK1250983B (zh) 作为tlr7激动剂的7-(噻唑-5-基)吡咯并嘧啶化合物
HK1231871A1 (en) A process for the preparation of compound and synthetic intermediates thereof
HK1205105A1 (zh) 制备化合物的方法及其合成中间体

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 04 FEB 2024 BY CPA GLOBAL

Effective date: 20221224

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 04 FEB 2025 BY CPA GLOBAL

Effective date: 20231221

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 04 FEB 2026 BY ABHISHEK KUMAR - CPA-PTO PAYMENTS

Effective date: 20241219